4/A

PRIMARY DOCUMENT

Company: Ginkgo Bioworks Holdings, Inc.
Filed: October 6, 2023
Period of Report: October 2, 2023
Accession Number: 0001127602-23-025684

View Document ↗ View on SEC.gov ↗